Panthera Biopartners is a leading UK-based Site Management Organisation (SMO) dedicated to the efficient delivery of Phase II-IV clinical trials. By operating a network of purpose-built clinical research centers, Panthera provides pharmaceutical companies and CROs with access to highly targeted patient recruitment and high-quality data. Their expertise spans a wide range of therapeutic areas, including oncology, vaccines, cardiology, and neurology. With a patient-centric approach and a team of specialist consultants and investigators, Panthera focuses on advancing medical breakthroughs while ensuring a safe and supportive environment for trial participants across the UK.
